TDRL-551
TDRL-551 is a novel and potent replication protein A (RPA) inhibitor (IC50=18 µM) with potential anticancer activity.TDRL-551 inhibits RPA-DNA interaction and enhances the efficacy of platinum-based chemotherapy for lung and ovarian cancer.
Product Specifications
CAS Number
1644626-43-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
591.83
Molecular Formula
C25H23ClIN3O4
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog